
Foracort Inhaler
Asthma, Chronic Obstructive Pulmonary Disease
100mcg + 6mcg · 200mcg + 6mcg · 400mcg + 6mcg
Formoterol and budesonide inhaler for asthma and COPD. The budesonide reduces swelling while formoterol opens the airways.
Budesonide appears here in three inhaler products: Budecort Inhaler and Foracort Inhaler for asthma and COPD, and Rhinocort for allergic rhinitis and nasal polyps.

Asthma, Chronic Obstructive Pulmonary Disease
100mcg + 6mcg · 200mcg + 6mcg · 400mcg + 6mcg
Formoterol and budesonide inhaler for asthma and COPD. The budesonide reduces swelling while formoterol opens the airways.

Asthma, Chronic Obstructive Pulmonary Disease
100mcg · 200mcg
A budesonide inhaler for asthma and chronic obstructive pulmonary disease. It is a preventer, not a reliever, so it is used daily to reduce airway inflammation.
Budesonide is a corticosteroid. It reduces swelling and irritation in the airways, which eases the wheezing, coughing and chest tightness that signal an asthma attack. Because inhaled budesonide acts locally in the lungs, it carries less risk of whole-body steroid effects than a tablet or injection.
When paired with formoterol, as in Foracort Inhaler, the bronchodilator relaxes the muscles around the airways while budesonide calms the inflammation underneath. The two actions address different parts of the same problem.
Three products share budesonide as their active ingredient, but they are not interchangeable. Budecort Inhaler, made by Cipla, supplies budesonide alone in 100 mcg and 200 mcg strengths. Foracort Inhaler, also from Cipla, combines budesonide with formoterol across three strengths (100/6, 200/6 and 400/6 mcg) for Asthma and Chronic Obstructive Pulmonary Disease. Rhinocort, the brand-name version from AstraZeneca, treats allergic rhinitis and nasal polyps with the same corticosteroid delivered to the nose. The two Cipla inhalers sit within Respiratory Health; Rhinocort is listed under Allergy Relief.